CD274 and ovarian carcinoma: In summary, we have demonstrated that an oncolytic vaccinia virus markedly upregulates PD-L1 in the TME, and thereby synergizes with α-PD-L1 treatment leading to over 40% cures in aggressive models of peritoneal carcinomatosis from colon and ovarian cancers.